
1 

(1) These Regulations may be cited as the Cosmetic Products (Restriction of Chemical Substances) (No. 2) Regulations 2024 and come into force on 31st January 2025.
(2) These Regulations extend to England and Wales and Scotland.
2 

(1) Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products is amended as follows.
(2) At the end of the table in Annex 2 (list of substances prohibited in cosmetic products), insert the entries set out in Schedule 1 to these Regulations.
(3) At the end of the table in Annex 3 (list of substances which cosmetic products must not contain except subject to the restrictions laid down), insert the entries set out in Schedule 2 to these Regulations.
3 

(1) Notwithstanding the amendments in regulation 2(2), cosmetic products containing any of the substances set out in Schedule 1 to these Regulations at reference numbers 1680 to 1730 that are placed on the market on or before 20th April 2025 may continue to be made available on the market on or before 20th October 2025.
(2) Notwithstanding the amendments in regulation 2(2), cosmetic products containing any of the substances set out in Schedule 1 to these Regulations at reference numbers 1731 to 1743 that are placed on the market on or before 2nd September 2025 may continue to be made available on the market on or before 2nd March 2026.
(3) Notwithstanding the amendment in regulation 2(3), cosmetic products that are placed on the market on or before 20th June 2025 may continue to be made available on the market on or before 1st November 2025.
Justin Madders
Parliamentary Under-Secretary of State
Department for Business and Trade
11th December 2024
Schedule 1 
Regulation 2(2)


1680 Tetrafluoroethylene 116-14-3 204-126-9
1681 6,6'-di-tert-butyl-2,2'-methylenedi-p-cresol; [DBMC] 119-47-1 204-327-1
1682 (5-chloro-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone 688046-61-9 692-456-8
1683 (RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate 1101132-67-5 
1684 3-methylpyrazole 1453-58-3 215-925-7
1685 N-methoxy-N-[1-methyl-2-(2,4,6-trichlorophenyl)-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide; Pydiflumetofen 1228284-64-7 
1686 N-{2-[[1,1'-bi(cyclopropyl)]-2-yl]phenyl}- 3-(difluoromethyl)-1-methyl-1Hpyrazole-4-carboxamide; Sedaxane 874967-67-6 
1687 Thiophanate-methyl (ISO); dimethyl (1,2- phenylenedicarbamothioyl)biscarbamat; dimethyl 4,4’-(o-phenylene)bis(3- thioallophanate) 23564-05-8 245-740-7
1688 Mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt 8018-01-7 
1689 Trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] 12035-72-2 [1] 12035-71-1 [2] 234-829-6 [1] – [2]
1690 7-oxa-3-oxiranylbicyclo[4.1.0]heptane; 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide 106-87-6 203-437-7
1691 4-methylpentan-2-one; isobutyl methyl ketone (MIBK) 108-10-1 203-550-1
1692 Carbendazim (ISO); methyl benzimidazole-2-ylcarbamat 10605-21-7 234-232-0
1693 Dimethomorph (ISO); (E,Z)-4-(3-(4- chlorophenyl)-3-(3,4- dimethoxyphenyl)acryloyl)morpholine 110488-70-5; (1135441-72-3) 404-200-2
1694 1,2,4-triazole 288-88-0 206-022-9
1695 Flumioxazin (ISO); N-(7-fluoro-3,4- dihydro-3-oxo-4-prop-2-ynyl-2H-1,4- benzoxazin-6-yl)cyclohex-1-ene-1,2- dicarboximide 103361-09-7 
1696 Imazamox (ISO); (RS)-2-(4-isopropyl-4- methyl- 5-oxo-2-imidazolin-2-yl)-5- methoxymethylnicotinic acid 114311-32-9 
1697 Thiamethoxam (ISO); 3-(2-chloro-thiazol-5-ylmethyl)-5- methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine 153719-23-4 428-650-4
1698 Triticonazole (ISO); (RS)-(E)-5-(4- chlorobenzylidene)-2,2-dimethyl-1-(1H1,2,4-triazol-1-ylmethyl)cyclopentanol 138182-18-0 
1699 Desmedipham (ISO); ethyl 3-phenylcarbamoyloxyphenylcarbamate 13684-56-5 237-198-5
1700 Tellurium dioxide 7446-07-3 231-193-1
1701 Tellurium 13494-80-9 236-813-4
1702 Fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5- (trifluoromethyl)-2- pyridylmethyl]benzamide 239110-15-7 607-285-6
1703 Daminozide (ISO); 4-(2,2- dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid 1596-84-5 216-485-9
1704 Benzophenone 119-61-9 204-337-6
1705 Acetamiprid (ISO); (1E)-N-[(6- chloropyridin-3- yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N 1 -[(6- chloro-3-pyridyl)methyl]-N 2 -cyano-N 1 – methylacetamidine 135410-20-7 603-921-1
1706 Theophylline; 1,3-dimethyl-3,7-dihydro-1
H-purine-2,6-dione
 58-55-9 200-385-7
1707 N-(2-nitrophenyl)phosphoric triamide
 874819-71-3 477-690-9
1708 Dibutyltin di(acetate) 1067-33-0 213-928-8
1709 Dibutyltin bis(2-ethylhexanoate) 2781-10-4 220-481-2
1710 Cumene 98-82-8 202-704-5
1711 Barium diboron tetraoxide 13701-59-2 237-222-4
1712 2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3- propanediyldiacrylate; 2,2- bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate 15625-89-5 239-701-3
1713 Quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone 2797-51-5 220-529-2
1714 Pendimethalin (ISO); N-(1-ethylpropyl)- 2,6-dinitro-3,4-xylidene 40487-42-1 254-938-2
1715 Isoflucypram (ISO); N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide 1255734-28-1 
1716 Dimoxystrobin (ISO); (2E)-2-{2-[(2,5- dimethylphenoxy)methyl]phenyl}-2- (methoxyimino)-N-methylacetamide; (E)-2- (methoxyimino)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl]acetamide 149961-52-4 604-712-8
1717 2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2- bis(bromomethyl)propan-1-ol 36483-57-5; 1522-92-5 253-057-0
1718 2,4,6-tri-tert-butylphenol 732-26-3 211-989-5
1719 Ammonium bromide 12124-97-9 235-183-8
1720 Divanadium pentaoxide; Vanadium pentoxide 1314-62-1 215-239-8
1721 Bentazone (ISO); 3-isopropyl-2,1,3- benzothiadiazine-4-one-2,2-dioxide 25057-89-0 246-585-8
1722 Margosa extract. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents] 84696-25-3 283-644-7
1723 Valifenalate (ISO); methyl N-(isopropoxycarbonyl)-L-valyl- (3RS)-3- (4-chlorophenyl)-β-alaninate 283159-90-0 
1724 Isopyrazam (ISO); reaction mass of 3-(difluoromethyl)-1-methyl-N- [(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4- methanonaphthalen-5-yl]pyrazole-4-carboxamide and 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4- tetrahydro-9-isopropyl-1,4-methanonaphthalen-5- yl]pyrazole-4-carboxamide [>78% syn isomers ≤ 15% anti isomers relative content]; 881685-58-1 
1725 Perfluoroheptanoic acid; tridecafluoroheptanoic acid 375-85-9 206-798-9
1726 4,4’-sulphonyldiphenol; bisphenol S 80-09-1 201-250-5
1727 6-[C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid (tetra-PSCA) 2156592-54-8 701-118-1
1728 6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid (Penta-PSCA)  701-162-1
1729 [C12-18-alkyl-(branched, unsaturated)- 2,5-dioxopyrrolidin-1-yl] hexanoic acid, sodium and tris(2-hydroxyethyl) ammonium salts; (penta-PSCA Na-TEA)  701-271-4
1730 1,3,5-triazine-2,4,6-triamine; melamine 108-78-1 203-615-4
1731 Benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate 577705-90-9 479-100-5
1732 Benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1) 75768-65-9 278-305-5
1733 Reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate (1:1)  
1734 Reaction mass of 4,4'-[2,2,2-trifluoro 1-(trifluoromethyl)ethylidene] diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1- (trifluoromethyl)ethylidene]bis[phenol] (1:1)  
1735 Reaction mass of 1-(2,3-epoxypropoxy)-2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2- ((2,3-epoxypropoxy)methyl) -2-hydroxymethyl butane  
1736 4,4'-[2,2,2-trifluoro-1- (trifluoromethyl)ethylidene]diphenol; bisphenol AF 1478-61-1 216-036-7
1737 Transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate 118712-89-3 405-060-5
1738 Salts of 2-ethylhexanoic acid  
1739 Benfluralin (ISO); N-butyl-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine 1861-40-1 217-465-2
1740 N,N-dimethyl-p-toluidine 99-97-8 202-805-4
1741 4-nitrosomorpholine 59-89-2 
1742 3,3'-dimethylbiphenyl 4,4'-diyl diisocyanate 91-97-4 202-112-7
1743 Foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea 173159-57-4 

Schedule 2 
Regulation 2(3)


323 5-hydroxy-2-(hydroxymethyl)pyran-4-one Kojic acid 501-30-4 207-922-4 Face and hand products 1%  
